Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Blocking LFA-1 prevents hair loss in mice.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Interleukin 6 may help protect skin without causing inflammation.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Topical IKKα inhibitors may help prevent CCS tumours.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Interleukin-1 increases keratin K6 production in skin cells.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

CS12192 effectively treats alopecia areata with better safety than current options.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

CCL 27 levels are similar in people with and without alopecia areata.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.